YS BIOPHARMA CO LTD (YS) Stock Analyst Ratings
NASDAQ:YS - KYG9845F1090 - Common Stock
1.02 USD
+0.11 (+12.45%)
1.07 USD
+0.05 (+4.9%)
ChartMill assigns a Buy % Consensus number of 84% to YS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.26. This target is 317.5% above the current price.
YS was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about YS.
In the previous month the buy percentage consensus was at a similar level.
YS was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-13 | Noble Capital Markets | Initiate | Outperform |